Understanding Myelofibrosis: Disease Spectrum and Impact on Quality of Life
January 24th 2024Aaron Gerds, MD, MS, compares myelofibrosis with other myeloproliferative neoplasms, explores its prevalence in the US, and reviews the diverse clinical presentations and the impact on patients’ quality of life.
Optimizing EoE Care in Pediatric Patients: Treatments and Shared Decision-Making
January 19th 2024Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.
Ensuring Equitable Patient Care in DME: Unconscious Bias Training and SDOH Screening
January 12th 2024Amy Nguyen Howell, MD, MBA, outlines vital practices for educating diverse patients on diabetic macular edema and its management while highlighting the need for unconscious bias training and social determinants of health screening.
Risk Evaluation and Mitigation Strategies [REMS] Program Considerations For Bispecific Therapy
January 12th 2024A panel discussion covers considerations within REMS programs aimed at minimizing risks associated with bispecific therapy. NOTE: Not all FDA-approved bispecific antibodies are associated with a REMS protocol.